Evidence map›Paper›PMID 28527510›Full record

ReviewChinese journal of natural medicines2017

Saposhnikoviae divaricata: a phytochemical, pharmacological, and pharmacokinetic review.

Jenny Kreiner, Edwin Pang, George Binh Lenon, Angela Wei Hong Yang

Abstract readReview
In one paragraph

Review in Chinese journal of natural medicines, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Article
  2. Article
  3. Plants (Basel, Switzerland) · 2026
    Article
  4. An Updated and Comprehensive Review ofMolecules (Basel, Switzerland) · 2026
    Review
  5. Chromosome-level genome assembly ofHorticulture research · 2026
    Article
  6. Article
  7. Aqueous extract ofBiochemistry and biophysics reports · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Integrative medicine research · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jenny KreinerSchool of Health and Biomedical Sciences, RMIT University, Victoria 3001, Australia.
Edwin PangSchool of Science, RMIT University, Victoria 3001, Australia.
George Binh LenonSchool of Health and Biomedical Sciences, RMIT University, Victoria 3001, Australia.
Angela Wei Hong YangSchool of Health and Biomedical Sciences, RMIT University, Victoria 3001, Australia. Electronic address: angela.yang@rmit.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Saposhnikoviae divaricata (Turcz.) Schischk (SD) is a traditional Chinese herb commonly used to treat clinical conditions such as rheumatism and allergic rhinitis. This review article evaluates a collection of works on in vitro and biochemical studies of SD. The discourse on the diverse class of chromones and coumarins in SD offers an insight to the pharmacological effects of these bioactive constituents as anti-inflammatory, analgesic, immunoregulatory, antioxidative, and anti-proliferative agents. It is highlighted that there is a structural relationship between the constituents and bioactive activities, which in effect provides a valid reasoning and reaffirm the use of SD in the treatment of the pathologies in Chinese medicine.

Indexed as

Drugs, Chinese HerbalAnimalsApiaceaeHumansDrugs, Chinese HerbalAnalgesicAnti-inflammatoryAnti-proliferativeChinese herbal medicineImmunomodulatorySaposhnikoviae divaricata

Identifiers

PMID28527510
PMCPMC7128302

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.